Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carroll

Showing results (891-900 of 1,434) with videos related to

Pageof 144
Sort By:
Plos One|October 11, 2017
Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)Michael S Leapman, Antonio C Westphalen, Niloufar Ameli, et al.
The Journal of Urology|October 8, 2013
Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™Jeffrey J Tomaszewski, Erin L Richman, Natalia Sadetsky, et al.
Head & Neck|April 29, 2020
Tracheotomy in the SARS-CoV-2 pandemicHunter Skoog, Kirk Withrow, Harishanker Jeyarajan, et al.
Urology|February 1, 2003
How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSUREMatthew R Cooperberg, Theresa M Koppie, Deborah P Lubeck, et al.
FEBS Letters|July 4, 1983
Synthetic peptides mimic subtype specificity of foot-and-mouth disease virusB E Clarke, A R Carroll, D J Rowlands, et al.
Bioconjugate Chemistry|March 1, 1996
Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugatesJ A Barrett, D J Damphousse, S J Heminway, et al.
Prostate Cancer and Prostatic Diseases|May 14, 2014
Updated trends in imaging use in men diagnosed with prostate cancerS P Porten, A Smith, A Y Odisho, et al.
The Journal of Urology|November 17, 2020
The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?Carissa E Chu, Janet E Cowan, Vittorio Fasulo, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2018
Practice patterns of primary EBRT with and without ADT in prostate cancer treatmentBogdana Schmidt, Renu S Eapen, Janet E Cowan, et al.
Journal of Medical Internet Research|June 23, 2020
Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional AnalysisPeter E Lonergan, Samuel L Washington Iii, Linda Branagan, et al.
Pageof 144

Showing results (891-900 of 1,434) with videos related to

Sort By:
Pageof 144
Plos One|October 11, 2017
Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)Michael S Leapman, Antonio C Westphalen, Niloufar Ameli, et al.
The Journal of Urology|October 8, 2013
Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™Jeffrey J Tomaszewski, Erin L Richman, Natalia Sadetsky, et al.
Head & Neck|April 29, 2020
Tracheotomy in the SARS-CoV-2 pandemicHunter Skoog, Kirk Withrow, Harishanker Jeyarajan, et al.
Urology|February 1, 2003
How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSUREMatthew R Cooperberg, Theresa M Koppie, Deborah P Lubeck, et al.
FEBS Letters|July 4, 1983
Synthetic peptides mimic subtype specificity of foot-and-mouth disease virusB E Clarke, A R Carroll, D J Rowlands, et al.
Bioconjugate Chemistry|March 1, 1996
Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugatesJ A Barrett, D J Damphousse, S J Heminway, et al.
Prostate Cancer and Prostatic Diseases|May 14, 2014
Updated trends in imaging use in men diagnosed with prostate cancerS P Porten, A Smith, A Y Odisho, et al.
The Journal of Urology|November 17, 2020
The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?Carissa E Chu, Janet E Cowan, Vittorio Fasulo, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2018
Practice patterns of primary EBRT with and without ADT in prostate cancer treatmentBogdana Schmidt, Renu S Eapen, Janet E Cowan, et al.
Journal of Medical Internet Research|June 23, 2020
Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional AnalysisPeter E Lonergan, Samuel L Washington Iii, Linda Branagan, et al.
Pageof 144